drugset / Trial / NCT02366299

Comparison of Dexmedetomidine and Propofol on the Delirium and Neuroinflammation in Patients With SIRS.

NCT02366299 ↗

RandomizedParallel-groupOpen-labelTreatment

Summary

Assessment of sedative effects of dexmedetomidine and propofol on the clinical course of delirium and neuroinflammation in patients with SIRS using CAM-ICU scale and protein S100b in serum.

Timeline

Start
2015-02
Primary completion
2018-12
Completion
2018-12

Drugs

EvaluationDrugModalityDoseRoute
Comparator Dexmedetomidine Other / unclassified — Intravenous
Comparator Propofol Small molecule — Intravenous

Indications